Related Experiment Video
Updated: Aug 10, 2026

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
A conceptual framework linking platelet activation, adaptive FGF21-GDF15 signaling, and islet vascular dysfunction in
Mustakin1, Mansyur Arif1, Liong Boy Kurniawan1
1Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Abstract:
Platelet activation, endothelial dysfunction, and stress-responsive endocrine signaling have emerged as important components of the complex biological processes underlying type 2 diabetes mellitus (T2DM), extending beyond the classical concepts of glucotoxicity and lipotoxicity. This review proposes a hypothesis-generating conceptual framework in which platelet activation, fibroblast growth factor 21 (FGF21), and growth differentiation factor 15 (GDF15) represent partly independent yet biologically interconnected stress-response pathways that may converge within the pancreatic islet microenvironment during disease progression. Activated platelets contribute to vascular inflammation and endothelial dysfunction through soluble mediators and extracellular vesicles, whereas FGF21 and GDF15 are induced by oxidative stress, mitochondrial dysfunction, and activation of integrated cellular stress responses as adaptive endocrine signals that promote mitochondrial homeostasis, endothelial integrity, and cellular resilience. Under persistent metabolic stress, sustained vascular injury, impaired adaptive signaling, and progressive endothelial dysfunction may collectively reduce the capacity of these protective mechanisms to preserve β-cell function. Rather than representing a proven transition point, the pancreatic islet microenvironment is proposed as a biologically plausible convergence site where vascular injury, adaptive endocrine responses, and intrinsic β-cell stress may interact. Although direct mechanistic evidence linking these pathways remains limited, this conceptual framework integrates current experimental and clinical evidence, identifies important mechanistic knowledge gaps, and provides a foundation for future mechanistic studies, integrated biomarker development, disease stratification, and precision medicine strategies in T2DM.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Type II Diabetes I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Retinopathy
